Clinical Laserthermia Systems AB (publ)

DB:LS60 Stock Report

Market Cap: €5.3m

Clinical Laserthermia Systems Past Earnings Performance

Past criteria checks 0/6

Clinical Laserthermia Systems's earnings have been declining at an average annual rate of -9.2%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 38.4% per year.

Key information

-9.2%

Earnings growth rate

33.6%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate38.4%
Return on equity-111.3%
Net Margin-344.7%
Next Earnings Update21 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Clinical Laserthermia Systems makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:LS60 Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2419-64640
30 Jun 2415-68660
31 Mar 2411-71670
31 Dec 238-80660
30 Sep 238-63530
30 Jun 237-77640
31 Mar 236-78640
31 Dec 226-71620
30 Sep 223-81690
30 Jun 222-63550
31 Mar 222-68570
31 Dec 212-64540
30 Sep 211-60510
30 Jun 212-57480
31 Mar 212-47400
31 Dec 201-58500
30 Sep 201-58520
30 Jun 202-57520
31 Mar 206-54550
31 Dec 196-43450
30 Sep 196-38410
30 Jun 195-37400
31 Mar 191-41410
31 Dec 188-33400
30 Sep 1810-28370
30 Jun 1811-24370
31 Mar 1812-15290
31 Dec 178-21320
30 Sep 178-22320
30 Jun 178-26340
31 Mar 176-27320
31 Dec 164-27300
30 Sep 161-27380
30 Jun 160-23300
31 Mar 160-20200
31 Dec 150-17170
30 Sep 150-21180
30 Jun 150-20130
31 Mar 150-20200
31 Dec 140-18180
30 Sep 140-1620
30 Jun 140-1600
31 Mar 140-1710

Quality Earnings: LS60 is currently unprofitable.

Growing Profit Margin: LS60 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: LS60 is unprofitable, and losses have increased over the past 5 years at a rate of 9.2% per year.

Accelerating Growth: Unable to compare LS60's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: LS60 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: LS60 has a negative Return on Equity (-111.3%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies